Jamila Battle, MD
Family Practice · Raleigh
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 14
- 2 carriers
- Offices
- 2
- Since medical school
- 22 years
- Graduated 2004
Offices
2 locations · Dreem Sleep Clinic of California · 32 clinicians in this group
Looking this up.
Plans that list them
14 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Battle’s office at (650) 761-4056 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
14 of 14 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
Checkups this office reported
4 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
| Asked about smokingPatients asked about tobacco, with help to quit if they smoke | 0%That's few of the people this applied to. | 25 |
| Cervical cancer screeningEligible women who got a Pap or HPV test | 0%That's few of the people this applied to. | 22 |
| Depression screeningPatients screened for depression, with a follow-up plan if needed | 0%That's few of the people this applied to. | 49 |
| Medications listed in the chartVisits where the current medication list was documented | 5%That's few of the people this applied to. | 77 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Implementation of medication management practice improvements
- Improved the patient portal
- Lets patients read their visit notes
- Uses standard treatment protocols
Medicaid work
$117,883 in 2019
Medicaid paid $117,883 for 3,296 billed services this clinician did in 2019, up to 140 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 809 | $68,173 |
| Short return visit (20+ min) | 313 | $16,652 |
| New patient visit (45+ min) | 63 | $7,244 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 108 | $5,894 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine (single or combination vaccine/toxoid) (List separately in addition to code for primary procedure) | 159 | $5,051 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 58 | $3,921 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 212 | $2,738 |
| Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; capable of being read by direct optical observation only (eg, utilizing immunoassay [eg, dipsticks, cups, cards, or cartridges]), includes sample validation when performed, per date of service | 120 | $1,483 |
| Service | 46 | $988 |
| Brief emotional/behavioral assessment (eg, depression inventory, attention-deficit/hyperactivity disorder [ADHD] scale), with scoring and documentation, per standardized instrument | 258 | $901 |
| Administration of caregiver-focused health risk assessment instrument (eg, depression inventory) for the benefit of the patient, with scoring and documentation, per standardized instrument | 264 | $815 |
| Administration of patient-focused health risk assessment instrument (eg, health hazard appraisal) with scoring and documentation, per standardized instrument | 260 | $774 |
| 2019 | 3,296 | 29 | 140 | $117,883 |
| 2018 | 2,834 | 21 | 151 | $100,389 |
See the largest Medicaid services in earlier years
2018
| Return visit (30+ min) | 950 | $58,831 |
| Short return visit (20+ min) | 456 | $18,156 |
| New patient visit (45+ min) | 61 | $6,127 |
| New patient visit (30+ min) | 53 | $3,348 |
| Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; capable of being read by direct optical observation only (eg, utilizing immunoassay [eg, dipsticks, cups, cards, or cartridges]), includes sample validation when performed, per date of service | 282 | $3,318 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine (single or combination vaccine/toxoid) (List separately in addition to code for primary procedure) | 84 | $2,283 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 190 | $2,197 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 18-39 years | 41 | $1,543 |
| Developmental screening | 154 | $1,095 |
| Short return visit | 35 | $943 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 15 | $857 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 77 | $678 |
Drugs they prescribed that Part D paid
$11,654
Pharmacies billed $11,654 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 48) in 2024. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
19 generic and 29 brand-name prescriptions · $11,654 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Zubsolv | 13 | $4,515 | $347 |
| Buprenorphine | 13 | $158 | $12 |
Year by year
| 2024 | 48 | None | 0% (0) | 60% | $11,654 |
| 2023 | 71 | None | 0% (0) | 34% | $15,504 |
| 2022 | 84 | None | 0% (0) | 31% | $19,149 |
| 2021 | 106 | None | 0% (0) | 40% | $21,751 |
| 2020 | 78 | None | 0% (0) | 49% | $19,246 |
| 2019 | 75 | 14 | 0% (0) | 45% | $13,357 |
| 2018 | 49 | None | 0% (0) | 37% | $7,139 |
| 2017 | 99 | 17 | 0% (0) | 26% | $11,204 |
| 2016 | 89 | 14 | 0% (0) | None | $3,068 |
| 2015 | 81 | 18 | 0% (0) | None | $1,623 |
| 2014 | 41 | 14 | 0% (0) | 0% | $3,170 |
| 2013 | 112 | 37 | None | 18% | $4,378 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Zubsolv | 12 | $7,693 | $641 |
| Buprenorphine-Naloxone | 11 | $1,805 | $164 |
| Buprenorphine | 14 | $267 | $19 |
2022: 4 drugs
| Zubsolv | 14 | $10,517 | $751 |
| Buprenorphine-Naloxone | 18 | $2,309 | $128 |
| Buprenorphine | 13 | $632 | $49 |
| Gabapentin | 15 | $223 | $15 |
2021: 5 drugs
| Zubsolv | 12 | $8,568 | $714 |
| Daytrana | 14 | $6,181 | $441 |
| Suboxone | 16 | $3,788 | $237 |
| Buprenorphine | 14 | $595 | $42 |
| Gabapentin | 14 | $90 | $6 |
2020: 4 drugs
| Zubsolv | 11 | $8,465 | $770 |
| Daytrana | 13 | $5,444 | $419 |
| Suboxone | 13 | $2,966 | $228 |
| Venlafaxine Hcl Er | 11 | $95 | $9 |
2019: 3 drugs
| Zubsolv | 13 | $5,809 | $447 |
| Buprenorphine-Naloxone | 15 | $2,360 | $157 |
| Buprenorphine | 14 | $1,368 | $98 |
2018: 2 drugs
| Suboxone | 18 | $4,888 | $272 |
| Buprenorphine | 14 | $1,237 | $88 |
2017: 3 drugs
| Suboxone | 26 | $9,537 | $367 |
| Gabapentin | 15 | $216 | $14 |
| Trazodone | 24 | $147 | $6 |
2016: 3 drugs
| Zolpidem | 20 | $737 | $37 |
| Gabapentin | 14 | $173 | $12 |
| Trazodone | 17 | $138 | $8 |
2015: 3 drugs
| Zolpidem | 18 | $564 | $31 |
| Gabapentin | 15 | $187 | $12 |
| Trazodone | 23 | $85 | $4 |
2013: 2 drugs
| Omeprazole | 12 | $162 | $13 |
| Metformin | 11 | $48 | $4 |
Money from drug and device companies
$2,551 in 2025
| 2025 | 4 | 8 | $2,100 | $2,551 |
| 2024 | 4 | 6 | None | $672 |
| 2023 | 3 | 16 | $6,813 | $7,834 |
| 2022 | 6 | 8 | None | $640 |
| 2021 | 2 | 2 | None | $36 |
| 2020 | 3 | 17 | None | $352 |
| 2019 | 5 | 16 | $175 | $551 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Lilly USA | Zepbound | $2,223 | 3 payments
|
| Jazz Pharmaceuticals | Xywav | $307 | 3 payments
|
| Boston Scientific | Wavewriter Alpha Prime 16 | $16 | 1 payment
|
| Itamar Medical | Watchpatone | $5 | 1 payment
|
See all 8 published payments
| Itamar Medical | Meals · 2025-08-28 | Watchpatone | $5 |
| Jazz Pharmaceuticals | Meals · 2025-06-11 | Xywav | $143 |
| Jazz Pharmaceuticals | Meals · 2025-06-10 | Xywav | $150 |
| Lilly USA | Paid to speak or teach · 2025-05-05 | Zepbound | $2,100 |
| Boston Scientific | Meals · 2025-03-27 | Wavewriter Alpha Prime 16 | $16 |
| Jazz Pharmaceuticals | Meals · 2025-03-25 | Xywav | $14 |
| Lilly USA | Meals · 2025-03-11 | Zepbound | $107 |
| Lilly USA | Meals · 2025-03-10 | Zepbound | $16 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $672
| Axsome Therapeutics | Sunosi | $234 | 2 payments
|
| Jazz Pharmaceuticals | None | $232 | 2 payments
|
| Avadel CNS Pharmaceuticals | Lumryz | $122 | 1 payment
|
| Noctrix Health | Nidra | $84 | 1 payment
|
2023: $7,834
| Idorsia Pharmaceuticals US | Quviviq | $7,403 | 11 payments
|
| Jazz Pharmaceuticals | Xywav | $408 | 4 payments
|
| Harmony Biosciences | Wakix | $23 | 1 payment
|
2022: $640
| Inspire Medical Systems | Inspire Upper Airway Stimulation System | $133 | 1 payment
|
| Novo Nordisk | Saxenda | $124 | 1 payment
|
| Jazz Pharmaceuticals | Xywav | $118 | 1 payment
|
| Idorsia Pharmaceuticals US | Quviviq | $107 | 2 payments
|
| Resmed | Air 11 | $96 | 1 payment
|
| Harmony Biosciences | Wakix | $62 | 2 payments
|
2021: $36
| Harmony Biosciences | Wakix | $18 | 1 payment
|
| Jazz Pharmaceuticals | Xywav | $18 | 1 payment
|
2020: $352
| Harmony Biosciences | Wakix | $270 | 12 payments
|
| Jazz Pharmaceuticals | Xyrem | $69 | 4 payments
|
| Indivior | Sublocade | $13 | 1 payment
|
2019: $551
| Indivior | Sublocade | $214 | 10 payments
|
| Otsuka Pharmaceutical Development & Commercialization | Abilify Mycite | $175 | 1 payment
|
| Alkermes | Aristada | $132 | 3 payments
|
| Jazz Pharmaceuticals | Xyrem | $16 | 1 payment
|
| Orexo US | Zubsolv | $14 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Indivior Inc. · A Phase II Double Blind, Placebo Controlled, Randomised, Dose-Ranging Study To Assess the Safety and Efficacy of Indv-2000 Over 3 Months in Treatment Seeking Individuals With Opioid Use Disorder · 2025 | Their institution | $76,627 |
| Indivior Inc. · A Phase II Double Blind, Placebo Controlled, Randomised, Dose-Ranging Study To Assess the Safety and Efficacy of Indv-2000 Over 3 Months in Treatment Seeking Individuals With Opioid Use Disorder · 2024 | Their institution | $34,328 |
Professional record
- NPI
- 1366560872
- Licence
- NC NC2008-01982
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- NC 5910881
- Taxonomy
- Federal specialty code 207QS1201X (207QS1201X); Family medicine (207Q00000X); Federal specialty code 207QA0401X (207QA0401X); Federal specialty code 207RA0401X (207RA0401X); Federal specialty code 207RS0012X (207RS0012X)
- Mailing address
- Po Box 1232, Wake Forest, NC, 27587
- NPI first listed
- 2007-03-26
- NPI last updated
- 2025-11-26
- NPI record certified
- 2025-11-26
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 333 Se 2nd Ave Ste 2000, Miami, FL, 33131 · 121 W 36th St # 237, New York, NY, 10018 · 7300 W 110th St Fl 7, Overland Park, KS, 66210 · 611 Gateway Blvd Ste 120, South San Francisco, CA, 94080